Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1131 | 1049 | 1261 | 1035 | 1442 | 1647 |
Fund Return | 13.1% | 4.94% | 26.06% | 1.14% | 7.6% | 5.11% |
Place in category | 25 | 56 | 53 | 69 | 64 | 37 |
% in Category | 24 | 72 | 49 | 84 | 76 | 79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 592.67B | 22.06 | 11.90 | 13.37 | ||
Fidelity Contrafund K | 12.16B | 31.38 | 12.49 | 15.34 | ||
Fidelity Contrafund | 136.16B | 31.29 | 12.42 | 15.24 | ||
Fidelity Total Market Index Instl b | 100.61B | 20.61 | 10.15 | 12.77 | ||
Fidelity Blue Chip Growth | 62.16B | 28.02 | 9.46 | 17.68 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard European Stock Index Adm | 5.18B | 12.78 | 6.19 | 5.82 | ||
Vanguard European Stock Index I | 904.87M | 12.79 | 6.22 | 5.85 | ||
DFA Continental Small Company I | 795.44M | 10.43 | 2.39 | 8.05 | ||
T. Rowe Price European Stock | 453.53M | 11.39 | 2.98 | 5.35 | ||
Brown Advisory WMC Strat Eurp Eq In | 334.39M | 18.86 | 9.22 | 8.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.53 | 745.4 | -0.96% | |
ASML Holding | NL0010273215 | 5.14 | 624.00 | +0.94% | |
AstraZeneca | GB0009895292 | 4.15 | 10,114.0 | -8.40% | |
SAP | DE0007164600 | 3.75 | 215.650 | +0.87% | |
Louis Vuitton | FR0000121014 | 2.97 | 602.60 | -0.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review